RecruitingPhase 3NCT06408181

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

Studying Preeclampsia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Pennsylvania
Principal Investigator
Enrique Schisterman, PhD
University of Pennsylvania
Intervention
Aspirin 162 mg(drug)
Enrollment
1150 target
Eligibility
18-45 years · FEMALE
Timeline
20242029

Study locations (1)

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06408181 on ClinicalTrials.gov

Other trials for Preeclampsia

Additional recruiting or active studies for the same condition.

See all trials for Preeclampsia

← Back to all trials